Document Detail


Cariporide for pharmacologic defibrillation after prolonged cardiac arrest.
MedLine Citation:
PMID:  12232565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: We hypothesized that cariporide, a sodium-hydrogen exchange inhibitor, would be as cardioprotective during the global myocardial ischemia of prolonged cardiac arrest as it is in settings of coronary occlusion. METHODS AND RESULTS: Fifteen Sprague-Dawley rats were randomized to receive bolus injections of cariporide or placebo in a dose of 3 mgxkg(-1) into the right atrium either 5 minutes before, or at 8 minutes after, onset of ventricular fibrillation. Ventricular fibrillation was electrically induced and untreated for 8 minutes. Precordial compression, together with mechanical ventilation, was then started and continued for an interval of 8 minutes prior to attempted resuscitation. All but one placebo-treated animal were successfully resuscitated. Spontaneous defibrillation with restoration of circulation was observed in both cariporide-pretreatment and post-treatment groups but in none of the placebo-treated animals. Postresuscitation cardiac index, end-tidal CO(2), mean aortic pressure, left ventricular systolic pressure, left ventricular end-diastolic pressure, and left ventricular contractile and lusitropic functions (dP/dt(40), and -dP/dt) were significantly less impaired after cariporide, especially in the pretreated group, compared to electrically defibrillated controls. Postresuscitation ventricular premature beats were significantly reduced after cariporide. The duration of post-resuscitation survival was significantly increased in animals pretreated with cariporide. CONCLUSIONS: Cariporide, when administered prior to and during cardiac arrest, improved both the success of resuscitation and postresuscitation myocardial function.
Authors:
Shue-ren Wann; Max Harry Weil; Shijie Sun; Wanchun Tang; Ting Yu
Related Documents :
20224485 - Predictors of poor neurologic outcome in patients undergoing therapeutic hypothermia af...
12031765 - Familial left ventricular hypertrabeculation in two blind brothers.
2030505 - Adequate crystalloid resuscitation restores but fails to maintain the active hepatocell...
16769925 - Critical time window for intra-arrest cooling with cold saline flush in a dog model of ...
3304965 - Disopyramide. a reappraisal of its pharmacodynamic and pharmacokinetic properties, and ...
9439545 - Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiovascular pharmacology and therapeutics     Volume:  7     ISSN:  1074-2484     ISO Abbreviation:  J. Cardiovasc. Pharmacol. Ther.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-09-16     Completed Date:  2003-03-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9602617     Medline TA:  J Cardiovasc Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  161-9     Citation Subset:  IM    
Affiliation:
Institute of Critical Care Medicine, Palm Springs, CA 92264, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Electric Countershock / methods
Guanidines / therapeutic use*
Heart Arrest / drug therapy*,  physiopathology
Male
Rats
Rats, Sprague-Dawley
Sulfones / therapeutic use*
Ventricular Fibrillation / drug therapy*,  physiopathology
Grant Support
ID/Acronym/Agency:
HL-54322/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Guanidines; 0/Sulfones; 0/cariporide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrill...
Next Document:  Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality.